Sujana Receives $800,000 NIH Grant

Sujana Biotech has been awarded a $805,182 grant to support the development of a novel therapeutic for the treatment of a range of vascular and inflammatory diseases. The award is funded through the NHLBI's Vascular Innovations and Therapeutic Advances (VITA) program, an NIH translational initiative that accelerates the development of novel therapeutics for unmet medical needs. Sujana is based on the work of a Harrington scholar and technology licensed from Case Western Reserve and University Hospitals in Cleveland, with collaborations at the Cleveland Clinic.